HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

NeuroVax vaccine

consists of three T-cell receptor peptides; undergoing phase II clinical trials for treatment of multiple sclerosis in 12/2005
Networked: 0 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results